| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |